GoldStone Asia Pharm Overview
- Year Founded
-
1991
- Status
-
Public
- Employees
-
1,794
- Stock Symbol
-
300434
- Investments
-
4
- Share Price
-
$1.62
- (As of Wednesday Closing)
GoldStone Asia Pharm General Information
Description
Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.
Contact Information
Website
www.goldstone-group.comCorporate Office
- Floor 8, Area A1, Dadi Xinguanghua Plaza
- No. 8 Jiayuan Road, Qingyang District
- Chengdu, Sichuan 610200
- China
Corporate Office
- Floor 8, Area A1, Dadi Xinguanghua Plaza
- No. 8 Jiayuan Road, Qingyang District
- Chengdu, Sichuan 610200
- China
GoldStone Asia Pharm Stock Performance
As of 18-Nov-2026, GoldStone Asia Pharm’s stock price is $1.62. Its current market cap is $651M with 402M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.62 | $1.67 | $1.27 - $2.15 | $651M | 402M | 29M | $0.06 |
GoldStone Asia Pharm Financials Summary
As of 30-Sep-2026, GoldStone Asia Pharm has a trailing 12-month revenue of $151M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 721,754 | 554,574 | 388,104 | 531,566 |
| Revenue | 150,956 | 144,395 | 153,628 | 170,914 |
| EBITDA | 29,256 | 35,355 | 31,102 | 36,751 |
| Net Income | 25,600 | 18,303 | 12,788 | 17,838 |
| Total Assets | 476,240 | 460,961 | 418,467 | 437,525 |
| Total Debt | 15,831 | 10,862 | 10,665 | 16,199 |
GoldStone Asia Pharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GoldStone Asia Pharm Signals
GoldStone Asia Pharm Investments & Acquisitions (4)
GoldStone Asia Pharm’s most recent deal was a Later Stage VC with Solipharma for . The deal was made on 28-Aug-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Solipharma | 28-Aug-2019 | Later Stage VC | Drug Discovery | ||
| GoldStone Asia Pharm | 16-Aug-2017 | Merger/Acquisition | Pharmaceuticals | ||
| Hainan Asia Pharmaceutical Group | 01-Aug-2017 | Merger/Acquisition | Pharmaceuticals | ||
| GoldStone Asia Pharm | 05-Aug-1991 | Joint Venture | Pharmaceuticals |
GoldStone Asia Pharm ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Machinery
Industry
Rank
Percentile
Industrial Machinery
Subindustry
Rank
Percentile
GoldStone Asia Pharm FAQs
-
When was GoldStone Asia Pharm founded?
GoldStone Asia Pharm was founded in 1991.
-
Where is GoldStone Asia Pharm headquartered?
GoldStone Asia Pharm is headquartered in Chengdu, China.
-
What is the size of GoldStone Asia Pharm?
GoldStone Asia Pharm has 1,794 total employees.
-
What industry is GoldStone Asia Pharm in?
GoldStone Asia Pharm’s primary industry is Pharmaceuticals.
-
Is GoldStone Asia Pharm a private or public company?
GoldStone Asia Pharm is a Public company.
-
What is GoldStone Asia Pharm’s stock symbol?
The ticker symbol for GoldStone Asia Pharm is 300434.
-
What is the current stock price of GoldStone Asia Pharm?
As of 18-Nov-2026 the stock price of GoldStone Asia Pharm is $1.62.
-
What is the current market cap of GoldStone Asia Pharm?
The current market capitalization of GoldStone Asia Pharm is $651M.
-
What is GoldStone Asia Pharm’s current revenue?
The trailing twelve month revenue for GoldStone Asia Pharm is $151M.
-
What is GoldStone Asia Pharm’s annual earnings per share (EPS)?
GoldStone Asia Pharm’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process